David Wilfret
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Liver Disease Diagnosis and Treatment 4
- Hepatitis B Virus Studies 2
- Respiratory viral infections research 2
-
- SARS-CoV-2 detection and testing 2
- HIV/AIDS drug development and treatment 2
- COVID-19 Clinical Research Studies 2
- Co-authors
- Shuguang Chen (2 shared papers)Stephen C. Piscitelli (2 shared papers)William Spreen (3 shared papers)Susan L. Ford (1 shared paper)David M. Margolis (1 shared paper)Elizabeth Gould (1 shared paper)Alan D. Hutson (1 shared paper)John W. Sleasman (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Pediatrics (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
David Wilfret
17 papers receiving 359 citations
Peers
Comparison fields: 5 of 64
- Virology 110
- Infectious Diseases 171
- Hepatology 30
- Emergency Medicine 24
- Epidemiology 58
Countries citing papers authored by David Wilfret
This map shows the geographic impact of David Wilfret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wilfret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wilfret more than expected).
Fields of papers citing papers by David Wilfret
This network shows the impact of papers produced by David Wilfret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wilfret. The network helps show where David Wilfret may publish in the future.
Co-authors
The 25 scholars most cited alongside David Wilfret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 118 | |
| 2 | 1999 | 64 | |
| 3 | 2010 | 40 | |
| 4 | 2020 | 32 | |
| 5 | 2014 | 31 | |
| 6 | 2020 | 23 | |
| 7 | 2013 | 21 | |
| 8 | 2014 | 10 | |
| 9 | 2008 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2024 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2013 | 2 | |
| 15 | 2014 | 2 | |
| 16 | 2014 | 1 | |
| 17 | 2009 | 1 |
About David Wilfret
David Wilfret is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Public Health, Environmental and Occupational Health and Pharmacology, having authored 17 papers that have together received 368 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Hepatitis C virus research (4 papers), Streptococcal Infections and Treatments (2 papers), SARS-CoV-2 detection and testing (2 papers), Hepatitis B Virus Studies (2 papers), Respiratory viral infections research (2 papers), HIV/AIDS drug development and treatment (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Virology (110 citations), Infectious Diseases (171 citations), Hepatology (30 citations), Emergency Medicine (24 citations) and Epidemiology (58 citations). David Wilfret has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Shuguang Chen, Stephen C. Piscitelli, William Spreen, Susan L. Ford, David M. Margolis, Elizabeth Gould, Alan D. Hutson, John W. Sleasman, Philip A. Pizzo and Robert P. Nelson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Pediatrics, Diagnostic Microbiology and Infectious Disease, CPT Pharmacometrics & Systems Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.